Skandinaviska Enskilda Banken (SEB)’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,700
Closed -$436K 1102
2021
Q1
$436K Hold
13,700
﹤0.01% 947
2020
Q4
$313K Buy
+13,700
New +$315K ﹤0.01% 962

Other funds holding MGNX

Skandinaviska Enskilda Banken (SEB)'s MGNX Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 13,700 shares — an estimated $436K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MGNX in Q4 2020 and held it in 2 quarters. The position peaked at $436K in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 13,700 MacroGenics shares in Q2 2021, an estimated $436K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in MacroGenics in Q4 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s MacroGenics position peaked at $436K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.